Allergy Therapeutics (LON:AGY) Stock Price Passes Above Fifty Day Moving Average of $4.68

Allergy Therapeutics plc (LON:AGY) crossed above its 50 day moving average during trading on Monday . The stock has a 50 day moving average of GBX 4.68 ($0.06) and traded as high as GBX 4.75 ($0.06). Allergy Therapeutics shares last traded at GBX 4.53 ($0.06), with a volume of 195,396 shares.

Allergy Therapeutics Stock Up 2.3 %

The firm has a 50 day simple moving average of GBX 4.68 and a two-hundred day simple moving average of GBX 4.04. The company has a quick ratio of 1.48, a current ratio of 1.40 and a debt-to-equity ratio of 37.22. The stock has a market capitalization of £220.85 million, a P/E ratio of -75.42, a PEG ratio of -30.70 and a beta of 1.40.

Allergy Therapeutics Company Profile

Allergy Therapeutics plc, a commercial biotechnology company, engages in the research and development of allergy treatments. The company sells injectable and sublingual allergen-specific immunotherapies; and offers prescription for the treatment of pollen-related allergies particularly to grasses, weeds, and trees, as well as diagnostics.